Coley Fluid

WikiDoc Resources for Coley Fluid
Articles
Most recent articles on Coley Fluid Most cited articles on Coley Fluid Review articles on Coley Fluid Articles on Coley Fluid in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Coley Fluid Images of Coley Fluid Photos of Coley Fluid Podcasts & MP3s on Coley Fluid Videos on Coley Fluid
Evidence Based Medicine
Cochrane Collaboration on Coley Fluid Bandolier on Coley Fluid TRIP on Coley Fluid
Clinical Trials
Ongoing Trials on Coley Fluid at Clinical Trials.gov Trial results on Coley Fluid Clinical Trials on Coley Fluid at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Coley Fluid NICE Guidance on Coley Fluid NHS PRODIGY Guidance FDA on Coley Fluid CDC on Coley Fluid
Books
Books on Coley Fluid
News
Coley Fluid in the news Be alerted to news on Coley Fluid News trends on Coley Fluid
Commentary
Blogs on Coley Fluid
Definitions
Definitions of Coley Fluid
Patient Resources / Community
Patient resources on Coley Fluid Discussion groups on Coley Fluid Patient Handouts on Coley Fluid Directions to Hospitals Treating Coley Fluid Risk calculators and risk factors for Coley Fluid
Healthcare Provider Resources
Symptoms of Coley Fluid Causes & Risk Factors for Coley Fluid Diagnostic studies for Coley Fluid Treatment of Coley Fluid
Continuing Medical Education (CME)
CME Programs on Coley Fluid
International
Coley Fluid en Espanol Coley Fluid en Francais
Business
Coley Fluid in the Marketplace Patents on Coley Fluid
Experimental / Informatics
List of terms related to Coley Fluid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Coley Fluid is a modern reformulation of a historical cancer therapy called Coley Vaccine developed by Dr. William B. Coley that was an effective treatment for many forms of cancer including advanced breast cancer.

The authors of a 1982 study concluded five year survival rates of historical Coley Vaccine patients is indistinguishable from five-year survival of modern patients.

In 1999, researchers found ten-year survival was higher in historical Coley Vaccine patients compared to modern sarcoma, kidney and ovarian cancer patients.

Coley Fluid is manufactured by MBVax Bioscience Inc, Ancaster, Canada.

References

Template:WS